Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum
David García(University of Washington Medical Center), Jack Ansell(New York University), Ann K. Wittkowsky(University of Washington), Stephan Moll(University of North Carolina at Chapel Hill), Amir K. Jaffer(Rush University Medical Center), Geno J. Merli(Thomas Jefferson University), Mark Crowther(McMaster University), Elaine M. Hylek(Boston University), Edith A. Nutescu(University of Illinois Chicago), Laura E. Earl(University of New Mexico), Alan K. Jacobson(VA Loma Linda Healthcare System), Richard C. Becker(Sabin Vaccine Institute), Lynn Oertel(Massachusetts General Hospital), Daniel M. Witt(University of Utah)
Cited by 105
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|Heart Rhythm|2017|2.7k
Prevention of VTE in Nonorthopedic Surgical Patients
|CHEST Journal|2012|2.1k